4225-85-8

Basic information

• Product Name: 2-Chloro-8-methylquinoline
• Synonyms: 2-Chloro-8-methylquinoline
• CAS NO: 4225-85-8
• Molecular Formula: C₁₀H₈ClN
• Molecular Weight: 177.63022
• Mol File: 4225-85-8.mol

Chemical Properties

• Melting Point: 61°C
• Boiling Point: 292.84°C (rough estimate)
• Appearance: /
• Density: 1.1810 (rough estimate)
• Refractive Index: 1.6224 (estimate)
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 2-Chloro-8-methylquinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chloro-8-methylquinoline(4225-85-8)
• EPA Substance Registry System: 2-Chloro-8-methylquinoline(4225-85-8)

Safety Data

• Hazardous Substances Data: 4225-85-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Chloro-8-methylquinoline is utilized as a building block in the synthesis of pharmaceutical drugs, contributing to the development of new therapeutic agents.
Used in Organic Synthesis:
2-Chloro-8-methylquinoline serves as a reagent in organic synthesis, facilitating the creation of various chemical products through its reactive properties.
Used in Agrochemical Production:
2-Chloro-8-methylquinoline is employed as an intermediate in the production of agrochemicals, playing a crucial role in the development of agricultural products.
Used in Research and Development:
2-Chloro-8-methylquinoline is used as a subject of research for its biological and pharmacological properties, with a focus on its potential as an anti-inflammatory and anti-cancer agent, indicating its importance in advancing medical science.

Upstream product

• 611-32-5 8-methylquinoline 
• 78987-21-0 (E)-N-(2-methylphenyl)-3-phenylacrylamide 
• 4053-36-5 8-methylquinolin-2-(1H)-one 
• 95-53-4 o-toluidine 
• 4053-38-7 8-methylquinoline 1-oxide 
• 35359-35-4 1,8-dimethyl-1,2-dihydroquinolin-2-one 
• 10026-13-8 phosphorus pentachloride 
• 10025-87-3 trichlorophosphate 

Downstream Products

• 4053-36-5 8-Methyl-2-hydroxyquinoline 
• 885687-65-0 2-methoxy-8-methyl-quinoline 
• 20151-45-5 2-Amino-8-methyl-chinolin 

Relevant articles and documents

C-Bridged Bispyrrolidines and Bispiperidines as New Ligands

The preparation of methylene-bridged C2-symmetric nitrogen-heterocycles as a new class of ligands is described, including methylene-bridged pyridines, quinolones, piperidines and pyrrolidines. These methylene-bridged aromatic systems are obtained via a microwave assisted Ziegler-type reaction. The separation of diastereomers and the application of the copper complexes of these ligands for cyclopropanation reactions proves the applicability of these new types of ligands.

Regioselective Chlorination of Quinoline N-Oxides and Isoquinoline N-Oxides Using PPh3/Cl3CCN

A novel method for the regioselective C2-chlorination of heterocyclic N-oxides has been developed. PPh3/Cl3CCN were used as chlorinating reagents and the desired N-heterocyclic chlorides were obtained smoothly in satisfactory yields. The reactions proceeded in a highly efficient and selective manner across a broad range of substrates demonstrating excellent functional group tolerance. In addition, this chlorination reaction can be used for the modification of N-heterocyclic scaffolds of appealing ligands and pharmaceuticals.

A practical and mild chlorination of fused heterocyclic N-oxides

Fused azine N-oxides were selectively chlorinated at C2 in moderate to excellent yields, employing Vilsmeier reagent as both the activating agent and the nucleophilic chloride source. Remarkable features of the method include simple operation, mild reaction conditions, a wide substrate scope, and the use of only stoichiometric amount of POCl3. The potential extension of this method to a one-pot oxidation/chlorination sequence that obviates the need for isolation of the N-oxide intermediates is also validated.

NITROGEN HETEROCYCLIC COMPOUNDS USEFUL AS PDE10 INHIBITORS

Unsaturated nitrogen heterocyclic compounds of formula (I): (I), as defined in the specification, compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, Huntington's Disease, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

7-PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES

Compounds of Formula I: (I) in which A, A1, R1, R7a, R7b, R8 and R10 have the meanings given in the specification, are DP2 receptor inhibitors useful in the treatment of useful in the treat